Insulin aspart, recombinant Subcutaneous and Mangafodipir Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Mangafodipir Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: mangafodipir
Brand name:
Synonyms: Mangafodipir (Intravenous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Manganese
- Insulin aspart, recombinant Subcutaneous-Mannitol
- Insulin aspart, recombinant Subcutaneous-Mannitol (Oral Inhalation)
- Insulin aspart, recombinant Subcutaneous-Mannitol (Systemic)
- Insulin aspart, recombinant Subcutaneous-Mannitol Inhalation
- Insulin aspart, recombinant Subcutaneous-Mannitol Injection
- Mangafodipir Intravenous-Insulin degludec
- Mangafodipir Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Mangafodipir Intravenous-Insulin Degludec (U-100) Vials
- Mangafodipir Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Mangafodipir Intravenous-Insulin degludec and liraglutide
- Mangafodipir Intravenous-Insulin degludec and liraglutide Subcutaneous